Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma

Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ . Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010; 60: 166–193.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109.

Bai RY, Staedtke V, Riggins GJ . Molecular targeting of glioblastoma: drug discovery and therapies. Trends Mol Med 2011; 17: 301–312.

Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT . Angiogenesis in brain tumours. Nat Rev Neurosci 2007; 8: 610–622.

Folkerth RD . Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neurooncol 2000; 50: 165–172.

Jouanneau E . Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 2008; 62: 31–50.

Chi AS, Sorensen AG, Jain RK, Batchelor TT . Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009; 14: 621–636.

Kerbel R, Folkman J . Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727–739.

Prensner JR, Chinnaiyan AM . The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391–407.

Batista PJ, Chang HY . Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298–1307.

Wang KC, Chang HY . Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43: 904–914.

Wang L, Shi ZM, Jiang CF, Liu X, Chen QD, Qian X et al. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget 2014; 5: 5416–5427.

Shi Z, Chen Q, Li C, Wang L, Qian X, Jiang C et al. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro Oncol 2014; 16: 1341–1353.

Yoon JH, Abdelmohsen K, Gorospe M . Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol 2014; 34: 9–14.

Tay Y, Rinn J, Pandolfi PP . The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344–352.

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353–358.

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358–369.

Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13: 92.

Rapicavoli NA, Blackshaw S . New meaning in the message: noncoding RNAs and their role in retinal development. Dev Dyn 2009; 238: 2103–2114.

Zhang Q, Geng PL, Yin P, Wang XL, Jia JP, Yao J . Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev 2013; 14: 2311–2315.

Han Y, Liu Y, Gui Y, Cai Z . Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol 2013; 107: 555–559.

Xu Y, Wang J, Qiu M, Xu L, Li M, Jiang F et al. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Tumour Biol 2014; 36: 1643–1651.

Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget 2015; 6: 19759–19779.

Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14: 382–393.

Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366–5383.

Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011; 30: 4750–4756.

Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg 2016; 124: 129–136.

Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal 2014; 27: 275–282.

Ke J, Yao YL, Zheng J, Wang P, Liu YH, Ma J et al. Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. Oncotarget 2015; 6: 21934–21949.

Zhou Y, Zhang X, Klibanski A . MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012; 48: R45–R53.

Young TL, Matsuda T, Cepko CL . The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol 2005; 15: 501–512.

Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta 2014; 431: 255–259.

Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 2014; 5: e1243.

Liu Q, Sun S, Yu W, Jiang J, Zhuo F, Qiu G et al. Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells. J Neurooncol 2015; 122: 283–292.

Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K . VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 2011; 17: 347–362.

Azoitei N, Pusapati GV, Kleger A, Moller P, Kufer R, Genze F et al. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut 2010; 59: 1316–1330.

Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 7843–7848.

Tate MC, Aghi MK . Biology of angiogenesis and invasion in glioma. Neurotherapeutics 2009; 6: 447–457.

Jiao F, Hu H, Han T, Yuan C, Wang L, Jin Z et al. Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci 2015; 16: 6677–6693.

Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun 2014; 5: 3596.

Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101–112.

Han X, Yang F, Cao H, Liang Z . Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis. FASEB J 2015; 29: 3054–3064.

Kobayashi H, Tomari Y . RISC assembly: coordination between small RNAs and Argonaute proteins. Biochim Biophys Acta 2016; 1859: 71–81.

Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013; 20: 1558–1568.

Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA et al. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med 2010; 14: 1693–1706.

Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro' E, Levine AJ et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene 2014; 33: 5173–5182.

Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.

Brat DJ, Bellail AC, Van Meir EG . The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 2005; 7: 122–133.

Dunn IF, Heese O, Black PM . Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol 2000; 50: 121–137.

Ezhilarasan R, Mohanam I, Govindarajan K, Mohanam S . Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process. Int J Oncol 2007; 30: 701–707.

Jafarifar F, Yao P, Eswarappa SM, Fox PL . Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J 2011; 30: 1324–1334.

Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710–1713.

Leon SP, Folkerth RD, Black PM . Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996; 77: 362–372.

Gaiser T, Becker MR, Meyer J, Habel A, Siegelin MD . p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas. Neurochem Int 2009; 54: 458–463.